温病学教学中的“三全育人”战略

温病学是中医学四大经典课程之一,是基础理论向临床实践过渡的桥梁课程,对于中医药高校学生具有重要意义。“三全育人”战略是高校思想政治工作的重点,新时期,我们应把“三全育人”战略贯穿温病学教育教学全过程和各环节,全员全过程全方位为培养具有坚实的温病理论知识和技能、医德高尚的现代化应用型中医药人才服务。     

中国医疗不良事件报告与质量改进的分析研究

文章分析了来自国家卫生健康委员会医政医管局收集的82万例不良事件报告中最常见的三项错误，该三项错误占82万例不良事件的53％；还介绍了抽样医院主动报告的五类不良事件，以及国家药品不良事件反应网络监测中心的药品与器械不良事件报告。介绍了北京中卫云医疗数据分析与应用研究院100万例误诊报告的简要内容，简要列举了6个典型误诊病例。介绍了中国政府主要的质量政策以及通过医院评审工作落实政策，改善医院管理的做法，引用《柳叶刀》杂志对中国医疗状况的评价，说明质量政策与医院评审对提升医疗服务安全质量是有效的。同时指出要警惕新发疾病，减少误诊，关注新技术、新材料、新药品应用时可能出现新的不安全事件，以实现高质量发展的目标。     

浅谈建立医疗意外保险制度

在我国司法实践中,对医疗意外的损害赔偿主要通过公平责任原则来处理,但是,这种责任分配模式对医患双方都有很大的局限性,不利于医疗纠纷的处理。尽快建立医疗意外保险制度,切实维护医患双方的合法权益,是解决此类纠纷的一个出口。该文从医疗意外保险的必要性出发,探讨应怎样设立医疗意外保险,保险的具体运作模式、保险赔付以及保险赔偿责任的范围等。     

医疗保险制度对老年群体死亡风险的影响——基于CLHLS的生存分析

目的:探讨医疗保险制度对老年群体死亡风险的影响,为我国医疗保障制度的改革与完善提供参考依据。方法:基于中国老年健康影响因素跟踪调查(CLHLS)2011—2014年的追踪数据,以添加脆弱因子的Weibull模型与Gompertz模型进行生存分析,并且分年龄组进行异质性分析。结果:相对于无医保的老人,有医保老人的死亡风险随医保制度的不同而发生不同程度的变化,具体而言,新农合、城镇居民基本医疗保险以及城镇职工基本医疗保险分别降低了约20%、25%以及31%的死亡风险。通过分年龄组进一步分析发现,医疗保险对高龄组老人死亡风险有显著影响,而对低龄组老人的死亡风险的影响不显著。结论:医疗保险制度有助于降低老年群体的死亡风险,但影响程度各异,表现为城镇职工医疗保险最高,城镇居民医疗保险次之,新农合最低。基于此,我国医疗保险制度改革的重点方向在于继续扩大医保覆盖面,并弥合不同医保之间的待遇差异,在统筹城乡居民医疗保险的基础上,进一步推进城镇职工医疗保险与居民医疗保险的整合,最终实现城乡医疗保险制度的一体化发展。     

The effect of malpractice law on physician supply: Evidence from negligence-standard reforms

We explore whether the composition of the physician workforce is impacted by the clinical standards imposed on physicians under medical liability rules. Specifically, we explore whether the proportion of non-surgeons practicing in a region decreases—and thus whether the proportion of surgeons increases—when liability standards are modified so as to expect that physicians practice more intensively. For these purposes, we draw on a quasi-experiment made possible by states shifting from local to national customs as the basis for setting liability standards. Using data from the Area Health Resource File from 1977 to 2005, we find that the rate of non-surgeons among practicing physicians decreases by 2–2.4 log points (or by 1.4–1.7 percentage points) following the adoption of national-standard laws in initially low surgery-rate regions—i.e., following a change in the law that effectively expects physicians to increase their use of surgical approaches.     

Rethinking “Elective” Procedures for Women's Reproduction during Covid-19

Common hospital and surgical center responses to the Covid-19 pandemic included curtailing “elective” procedures, which are typically determined based on implications for physical health and survival. However, in the focus solely on physical health and survival, procedures whose main benefits advance components of well-being beyond health, including self-determination, personal security, economic stability, equal respect, and creation of meaningful social relationships, have been disproportionately deprioritized. We describe how female reproduction-related procedures, including abortion, surgical sterilization, reversible contraception devices and in vitro fertilization, have been broadly categorized as “elective,” a designation that fails to capture the value of these procedures or their impact on women's overall well-being. We argue that corresponding restrictions and delays of these procedures are problematically reflective of underlying structural views that marginalize women's rights and interests and therefore threaten to propagate gender injustice during the pandemic and beyond. Finally, we propose a framework for triaging reproduction-related procedures during Covid-19 that is more individualized, accounts for their significance for comprehensive well-being, and can be used to inform resumption of operations as well as subsequent restriction phases.     

Interdependent Citizens: The Ethics of Care in Pandemic Recovery

The crisis of Covid-19 has forced us to notice two things: our human interdependence and American society's tolerance for what Nancy Krieger has called “inequalities embodied in health inequities,” reflected in data on Covid-19 mortality and geographies. Care is integral to our recovery from this catastrophe and to the development of sustainable public health policies and practices that promote societal resilience and reduce the vulnerabilities of our citizens. Drawing on the insights of Joan Tronto and Eva Feder Kittay, we argue that the ethics of care offers a critical alternative to utilitarian and deontological approaches and provides a street-ready framework for integration into public health deliberations to anchor public policy and investments concerning the recovery and future well-being of America's citizens and society.     

Avoiding Ineffective End-of-Life Care: A Lesson from Triage?

Ethicists and physicians all over the world have been working on triage protocols to plan for the possibility that the Covid-19 pandemic will result in shortages of intensive care unit beds, ventilators, blood products, or medications. In reflecting on those protocols, many health care workers have noticed that, outside the pandemic shortage situation, we routinely supply patients in the ICU with invasive and painful care that will not help the patients survive even their hospitalization. This is the kind of pointless care that even the most basic protocol would triage against. Perhaps this widespread reflection on triage standards will draw our attention to our ongoing custom of supplying burdensome and inefficacious care to those near the end of life—care that most health care providers would not want for themselves. This essay argues that reflecting on triage could help us improve end-of-life care.     

热敏灸治疗顽固性呃逆案

热敏灸作为一种新型的灸疗方法,《医宗金鉴》中述“凡灸诸病,必火足气到,始能求愈”,故热敏灸讲究“敏消量足”,举一临床顽固性呃逆病案加以细说。     

Excavating the Personal Genome: The Good Biocitizen in the Age of Precision Health

The rise of genomic technologies has catalyzed shifts in the health care landscape through the commercialization of genome sequencing and testing services in the genomics marketplace. The development of consumer genomics into a growing array of information technologies aimed at collecting, curating, and broadly sharing personal data and biological materials reconstitutes the meaning of health and reframes patients into biocitizens. In this context, the good biocitizen is expected to assume personal responsibility for health through consumption of genomic information and acquiescence to public and private efforts at data surveillance and aggregation. These shifts raise fundamental questions about how competing interests of the public, the state, and corporate entities will be reconciled and what trade-offs are demanded for the promise of precision health.